Contract Services Methods Development

Biogen to acquire full ownership of Samsung Bioepis

Agreement with Biogen to buyout Biogen's (50% -1 share) stake in Samsung Bioepis Joint Venture for up to USD $2.3 billion Transaction projected to ...

 January 28, 2022 | News

GenScript ProBio initiates a CDMO Contract For Next-Generation CD47 Antibody with InnoBation Bio

InnoBation Bio, led by Seung-gu Kim (CEO), is a biopharmaceutical company specializing in the development of biomarkers, Chimeric Antigen Receptor (CAR) T ...

 January 26, 2022 | News

WuXi STA Launches its First Parenteral Formulation Manufacturing Line

The industry-leading automatic parenteral filling line features multiple filling modules and a built-in lyophilizer to fill vials, syringes, and ...

 January 24, 2022 | News

GenScript ProBio to Expand Commercial cGMP Plasmid and Viral Vector

On January 19, 2022, GenScript ProBio broke ground for the construction of its newest plasmid and viral vector manufacturing facility, a 34,000-square...

 January 21, 2022 | News

Vetter's new clinical manufacturing site now officially authorized

Important milestone reached for the new site Additional filling capacities for early-stage clinical development First customer audits already completed...

 January 20, 2022 | News

WuXi Biologics completes the first GMP inspection in 2022

WuXi Biologics  a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by&n...

 January 18, 2022 | News

Samsung Biologics Shares Strategic Roadmap for Sustainable Growth

During the main track presentation today, John Rim, President and CEO of Samsung Biologics, addressed the company's vision for 2022 and business goals...

 January 13, 2022 | News

Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA

Merck, a leading science and technology company, has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufac...

 January 07, 2022 | News

GenScript ProBio To Expands It's Manufacturing Capacity in China

On December 7th, the "Opening Ceremony of GenScript ProBio Plasmid Commercial GMP Manufacturing facility and Open Day" was rounded off. GenS...

 December 08, 2021 | News

Immunomic Therapeutics Announces Collaboration With iOncologi

Immunomic Therapeutics, Inc., (“ITI”) a privately held clinical-stage biotechnology company focused on advancing its proprietary nucleic acid i...

 November 24, 2021 | News

WuXi Biologics Launches a New GMP Commercial Drug Product Facility

Enhances drug product services for projects at various stages, with an emphasis on late and commercial stage production Increases up to 60 million vials...

 November 01, 2021 | News

WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility

WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote G...

 October 28, 2021 | News

Samsung Biologics Reports Third Quarter 2021 Financial Results

Q3'21 revenue of KRW 450.7 billion increased 64% compared to Q3'20. Q3'21 operating profit of KRW 167.4 billion increased 196% compa...

 October 27, 2021 | News

Chinese BioPharma I-Mab Expands U.S. Footprint with New R&D Site

I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel bi...

 October 25, 2021 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close